Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NY › BROOKLYN › DORAL MEDICAL AND MULTI SPECIALTY FACILITY LLC

DORAL MEDICAL AND MULTI SPECIALTY FACILITY LLC

NPI: 1144693607 · BROOKLYN, NY 11212 · Multi-Specialty Clinic/Center · NPI assigned 11/05/2015

$7.77M
Total Medicaid Paid
287,912
Total Claims
196,643
Beneficiaries
186
Codes Billed
2020-04
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLIPSCHITZ, DAVID (PRESIDENT)
NPI Enumeration Date11/05/2015

Related Entities

Other providers sharing the same authorized official: LIPSCHITZ, DAVID

ProviderCityStateTotal Paid
THE DORAL INVESTORS GROUP, LLC DBA HOUSE CALLS HOME CARE BROOKLYN NY $497.09M
THE DORAL INVESTORS GROUP LLC BROOKLYN NY $34.29M
ALPHA & OMEGA KIDS DEVELOPMENTAL SERVICES BROOKLYN NY $11.94M
DORAL DIALYSIS LLC BROOKLYN NY $252K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 1,450 $8K
2021 12,987 $320K
2022 34,608 $1.65M
2023 131,231 $2.32M
2024 107,636 $3.48M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 65,206 20,438 $2.05M
T1015 Clinic visit/encounter, all-inclusive 13,608 10,488 $635K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 7,982 5,942 $569K
90832 Psychotherapy, 30 minutes with patient 5,988 3,430 $545K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 9,939 4,490 $512K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 4,149 3,366 $262K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2,178 1,853 $220K
G0445 High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes 2,319 2,242 $195K
99441 1,661 1,565 $193K
20552 1,068 931 $188K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 262 259 $140K
90791 Psychiatric diagnostic evaluation 770 728 $121K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 2,102 1,946 $120K
99443 2,217 1,719 $119K
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 1,409 1,240 $112K
99401 3,365 2,965 $109K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 1,027 828 $93K
93880 238 223 $91K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 509 440 $91K
90792 Psychiatric diagnostic evaluation with medical services 528 526 $87K
93970 198 184 $85K
99454 8,767 5,236 $81K
99000 5,385 4,415 $75K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 696 643 $66K
76942 389 376 $65K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 882 879 $65K
96160 1,471 1,387 $56K
99385 665 634 $53K
11900 160 148 $44K
11721 1,165 874 $41K
G0444 Annual depression screening, 5 to 15 minutes 1,489 1,476 $39K
99442 729 634 $37K
92201 589 584 $37K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 194 81 $33K
G0442 Annual alcohol misuse screening, 5 to 15 minutes 919 914 $32K
93925 94 87 $32K
99457 5,678 5,373 $29K
0002A 983 966 $27K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 363 359 $26K
0001A 1,047 1,017 $26K
76700 Ultrasound, abdominal, real time with image documentation; complete 47 46 $25K
99386 227 219 $23K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,296 1,160 $23K
99406 536 499 $22K
20611 57 46 $22K
H0001 Alcohol and/or drug assessment 198 198 $20K
2000F 14,413 6,665 $17K
99091 296 296 $13K
36415 Collection of venous blood by venipuncture 4,666 4,320 $12K
H0002 Behavioral health screening to determine eligibility for admission to treatment program 100 97 $12K
93975 21 21 $11K
86328 297 249 $10K
90834 Psychotherapy, 45 minutes with patient 61 42 $10K
0003A 292 260 $10K
1159F 8,690 6,562 $10K
95250 60 49 $9K
93015 58 58 $8K
17110 34 29 $8K
11056 25 25 $7K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 102 69 $7K
94060 27 27 $7K
90674 247 247 $6K
92133 69 68 $5K
51798 14 14 $5K
93000 693 544 $5K
1126F 5,496 3,833 $4K
81002 1,220 1,023 $4K
82962 553 278 $4K
57410 67 57 $3K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 26 26 $3K
95251 41 35 $3K
20610 14 12 $3K
T1013 Sign language or oral interpretive services, per 15 minutes 215 178 $2K
99453 457 296 $2K
92250 27 27 $2K
80305 1,373 1,210 $2K
10040 13 13 $2K
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 422 398 $2K
G0008 Administration of influenza virus vaccine 215 215 $2K
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 14 14 $2K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 1,519 1,138 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 83 81 $2K
92015 Determination of refractive state 474 466 $2K
99490 Ccm add 20min 291 274 $2K
S0610 Annual gynecological examination, new patient 26 26 $1K
20553 57 40 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 215 206 $1K
99051 113 113 $1K
Q3014 Telehealth originating site facility fee 112 72 $1K
99459 26 26 $1K
36000 40 40 $1K
11719 14 14 $887.51
92134 12 12 $655.01
J1030 Injection, methylprednisolone acetate, 40 mg 228 206 $579.55
87070 157 153 $518.60
3074F 3,951 3,398 $518.50
99458 354 341 $510.35
99050 80 80 $506.76
1125F 2,422 2,099 $390.80
90661 12 12 $360.76
J1100 Injection, dexamethasone sodium phosphate, 1 mg 968 892 $360.49
3079F 1,936 1,755 $355.16
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 942 754 $339.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 30 30 $332.24
99348 75 13 $284.22
3078F 3,222 2,797 $270.49
J1885 Injection, ketorolac tromethamine, per 15 mg 1,269 1,193 $263.85
2001F 6,189 5,281 $183.02
G8420 Bmi is documented within normal parameters and no follow-up plan is required 3,670 3,044 $150.40
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 15 15 $150.00
99344 14 14 $130.25
96127 114 113 $113.68
G9744 Patient not eligible due to active diagnosis of hypertension 447 405 $106.08
G8753 Most recent systolic blood pressure >= 140 mmhg 304 253 $103.36
81025 33 33 $97.01
3077F 907 807 $92.50
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 4,523 3,637 $88.68
G8752 Most recent systolic blood pressure < 140 mmhg 257 219 $88.40
3080F 604 537 $80.00
3075F 769 726 $77.50
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 1,510 1,316 $39.11
3028F 6,804 5,629 $38.21
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 38 38 $28.19
1160F 5,795 4,990 $24.70
2010F 6,553 5,576 $22.72
G9903 Patient screened for tobacco use and identified as a tobacco non-user 567 504 $10.27
3044F 927 845 $5.99
G8950 Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented 1,369 1,231 $3.19
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 81 71 $0.86
G8783 Normal blood pressure reading documented, follow-up not required 1,814 1,598 $0.28
G8754 Most recent diastolic blood pressure < 90 mmhg 392 352 $0.07
G8510 Screening for depression is documented as negative, a follow-up plan is not required 1,278 1,221 $0.07
G4028 Podiatry mips specialty set 542 528 $0.06
G9902 Patient screened for tobacco use and identified as a tobacco user 528 467 $0.05
G4018 Obstetrics/gynecology mips specialty set 818 784 $0.03
3008F 7,209 6,077 $0.01
1036F 2,618 2,247 $0.01
G8755 Most recent diastolic blood pressure >= 90 mmhg 73 70 $0.01
2018F 1,835 1,622 $0.01
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 76 75 $0.01
3754F 230 222 $0.00
1170F 159 150 $0.00
3048F 412 379 $0.00
J0280 Injection, aminophyllin, up to 250 mg 12 12 $0.00
4011F 214 181 $0.00
4010F 89 82 $0.00
1034F 557 473 $0.00
3279F 263 242 $0.00
3514F 68 67 $0.00
3049F 192 174 $0.00
M1207 Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety 106 101 $0.00
G8418 Bmi is documented below normal parameters and a follow-up plan is documented 693 581 $0.00
3510F 69 68 $0.00
1006F 64 64 $0.00
G2197 Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user 113 110 $0.00
G8419 Bmi documented outside normal parameters, no follow-up plan documented, no reason given 30 29 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 54 53 $0.00
1000F 193 171 $0.00
3011F 244 232 $0.00
4008F 47 41 $0.00
1220F 17 17 $0.00
90656 14 14 $0.00
3512F 65 61 $0.00
3120F 25 25 $0.00
G8404 Lower extremity neurological exam performed and documented 525 511 $0.00
2029F 551 492 $0.00
4004F 367 361 $0.00
2028F 547 531 $0.00
1137F 565 537 $0.00
1090F 75 70 $0.00
3725F 376 370 $0.00
3511F 377 355 $0.00
4013F 692 585 $0.00
1033F 634 589 $0.00
3280F 180 168 $0.00
3513F 68 67 $0.00
3015F 190 174 $0.00
3016F 143 129 $0.00
1100F 64 56 $0.00
G8482 Influenza immunization administered or previously received 16 16 $0.00
3050F 140 120 $0.00
4025F 23 17 $0.00
G9796 Patient is currently on a high intensity statin therapy 13 13 $0.00
3020F 27 25 $0.00
G9622 Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method 14 14 $0.00
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 27 27 $0.00